---
figid: PMC4287801__gr1
figtitle: Molecular pathogenesis and therapeutics of Marfan syndrome (MFS)
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4287801
filename: gr1.jpg
figlink: /pmc/articles/PMC4287801/figure/f0005/
number: F1
caption: 'Molecular pathogenesis and therapeutics of Marfan syndrome (MFS). At the
  cell surface, Fibrillin-1 directly binds a latent form of TGFβ binding protein (LTBP).
  TGF-β and angiotensin II (via Ang II receptor type 1, AT1R) activated Ras can induce
  ERK MAP signaling. JNK and p38 MAPK signaling are activated by various MAPK kinase
  kinases in response to varied stimuli. Whereas MAP/ERK kinases (MEK1) and TGF-β-activated
  kinases (TAK1) can activate ERK, JNK and p38 signaling pathways and thus relay the
  signal into the nucleus causing the transcription of target genes (non-canonical
  TGF β pathway). TGFβ downstream signaling involves SMAD 2, 3 and 4 (canonical TGF
  β pathway). MAPK: mitogen-activated protein kinases; TGF-β: transforming growth
  factor beta; JNK: Janus kinase.'
papertitle: 'Marfan syndrome: An eyesight of syndrome.'
reftext: Ashok Kumar, et al. Meta Gene. 2014 Dec;2:96-105.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9651682
figid_alias: PMC4287801__F1
figtype: Figure
redirect_from: /figures/PMC4287801__F1
ndex: 82de8a36-dec4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4287801__gr1.html
  '@type': Dataset
  description: 'Molecular pathogenesis and therapeutics of Marfan syndrome (MFS).
    At the cell surface, Fibrillin-1 directly binds a latent form of TGFβ binding
    protein (LTBP). TGF-β and angiotensin II (via Ang II receptor type 1, AT1R) activated
    Ras can induce ERK MAP signaling. JNK and p38 MAPK signaling are activated by
    various MAPK kinase kinases in response to varied stimuli. Whereas MAP/ERK kinases
    (MEK1) and TGF-β-activated kinases (TAK1) can activate ERK, JNK and p38 signaling
    pathways and thus relay the signal into the nucleus causing the transcription
    of target genes (non-canonical TGF β pathway). TGFβ downstream signaling involves
    SMAD 2, 3 and 4 (canonical TGF β pathway). MAPK: mitogen-activated protein kinases;
    TGF-β: transforming growth factor beta; JNK: Janus kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - dpp
  - gbb
  - put
  - mav
  - Tg
  - fb
  - anon-16Fa
  - Mat1
  - alphaTub84B
  - ras
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - tak
  - Tak1
  - Takl2
  - sma
  - lds
  - bsk
  - Erk7
  - rl
  - syndrome
  - Med
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - MKP-4
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - tf
  - Smox
  - Mad
  - TGFB1
  - TGFB2
  - TGFB3
  - ANGPT2
  - VPS51
  - TG
  - FBN1
  - AGTR1
  - ATM
  - SLC33A1
  - PGR-AS1
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - KRAS
  - HRAS
  - NRAS
  - MTG1
  - MAP3K7
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CDK9
  - SMN1
  - GUSBP14
  - GUSBP3
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - MAPK1
  - MAPK3
  - SMAD4
  - CRK
  - MAPK14
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - TF
  - SMAD1
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - Losartan
---
